These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 27152687)

  • 21. Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.
    Bruehl S; Apkarian AV; Ballantyne JC; Berger A; Borsook D; Chen WG; Farrar JT; Haythornthwaite JA; Horn SD; Iadarola MJ; Inturrisi CE; Lao L; Mackey S; Mao J; Sawczuk A; Uhl GR; Witter J; Woolf CJ; Zubieta JK; Lin Y
    J Pain; 2013 Feb; 14(2):103-13. PubMed ID: 23374939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dutch Dataset Pain Rehabilitation in daily practice: Content, patient characteristics and reference data.
    Köke AJ; Smeets RJ; Schreurs KM; van Baalen B; de Haan P; Remerie SC; Schiphorst Preuper HR; Reneman MF
    Eur J Pain; 2017 Mar; 21(3):434-444. PubMed ID: 27634023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A sore thing.
    Nature; 2015 Feb; 518(7540):456. PubMed ID: 25719627
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: a protocol for a methodological survey.
    Mazzei LG; Bergamaschi CC; Silva MT; Lopes LC
    BMJ Open; 2017 Sep; 7(9):e014904. PubMed ID: 28963280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analgesic Effects of Cannabinoids for Chronic Non-cancer Pain: a Systematic Review and Meta-Analysis with Meta-Regression.
    Wong SSC; Chan WS; Cheung CW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):801-829. PubMed ID: 32172501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.
    Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A
    Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endpoints in pediatric pain studies.
    van Dijk M; Ceelie I; Tibboel D
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1(Suppl 1):61-6. PubMed ID: 21107829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain.
    Rahman W; Dickenson AH
    Curr Opin Support Palliat Care; 2015 Jun; 9(2):124-30. PubMed ID: 25730180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness and acceptability of Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials core outcome set for chronic pain among surveyed neuropathic pain authors.
    Dosenovic S; Nikolic Z; Ivancev B; Jelicic Kadic A; Puljak L
    J Comp Eff Res; 2019 Jul; 8(9):671-683. PubMed ID: 31290689
    [No Abstract]   [Full Text] [Related]  

  • 30. Anxiety and its predictive value for pain and regular analgesic intake after lumbar disc surgery - a prospective observational longitudinal study.
    Laufenberg-Feldmann R; Kappis B; Cámara RJA; Ferner M
    BMC Psychiatry; 2018 Mar; 18(1):82. PubMed ID: 29587759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multidisciplinary care pathway to manage osteoarticular chronic pain. ASON proposal].
    Mammucari M; Gigliotti S; Pucino A; Capezza M; Santè G
    Recenti Prog Med; 2015 Mar; 106(3):118-24. PubMed ID: 25805222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the impact of gabapentinoids on sleep health in patients with chronic neuropathic pain: a systematic review and meta-analysis.
    Kapustin D; Bhatia A; McParland A; Trivedi A; Davidson A; Brull R; Singh M
    Pain; 2020 Mar; 161(3):476-490. PubMed ID: 31693543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual responder analyses for pain: does one pain scale fit all?
    Dionne RA; Bartoshuk L; Mogil J; Witter J
    Trends Pharmacol Sci; 2005 Mar; 26(3):125-30. PubMed ID: 15749157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic use by ageing and elderly patients with chronic non-malignant pain: a qualitative study.
    Kennedy MC; Cousins G; Henman MC
    Int J Clin Pharm; 2017 Aug; 39(4):798-807. PubMed ID: 28474305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giving priority to preclinical pain measures resistant to existing drugs for developing innovative analgesics.
    Nagakura Y
    Drug Dev Res; 2018 Jun; 79(4):147-156. PubMed ID: 29732584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing the early phase development of new analgesics by human pain biomarkers.
    Arendt-Nielsen L; Hoeck HC
    Expert Rev Neurother; 2011 Nov; 11(11):1631-51. PubMed ID: 22014141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic management of chronic low back pain: synthesis of the evidence.
    White AP; Arnold PM; Norvell DC; Ecker E; Fehlings MG
    Spine (Phila Pa 1976); 2011 Oct; 36(21 Suppl):S131-43. PubMed ID: 21952185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review of outpatient services for chronic pain control.
    McQuay HJ; Moore RA; Eccleston C; Morley S; Williams AC
    Health Technol Assess; 1997; 1(6):i-iv, 1-135. PubMed ID: 9483161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reporting of cross-over clinical trials of analgesic treatments for chronic pain: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review and recommendations.
    Gewandter JS; McDermott MP; McKeown A; Hoang K; Iwan K; Kralovic S; Rothstein D; Gilron I; Katz NP; Raja SN; Senn S; Smith SM; Turk DC; Dworkin RH
    Pain; 2016 Nov; 157(11):2544-2551. PubMed ID: 27437786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.